Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Transplantation and Cellular Therapy
|
February 4, 2023
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation
Mohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, et al.
Transplantation and Cellular Therapy
|
June 17, 2026
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis
Neela Easton, Mia Andreoli, Herman van Besien, et al.
JAMA Oncology
|
June 18, 2026
Second Primary Malignant Neoplasms After T-Cell-Engaging Bispecific Antibody Therapy: A Systematic Review and Meta-Analysis
Jaromir Tomasik, Tobias Tix, Mohammad Alhomoud, et al.
Haematologica
|
July 10, 2025
Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis
Mohammad Alhomoud, Rahma Ibrahim, Michelle Demetres, et al.
American Journal of Hematology
|
August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis
Jordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
Cancer Cell
|
December 6, 2024
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
Yusuke Isshiki, Xi Chen, Matt Teater, et al.
Blood Advances
|
May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
American Journal of Hematology
|
September 3, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies
Suheil Albert Atallah-Yunes, Chijioke C Nze, Rebecca L King, et al.
Blood Advances
|
March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin Lymphoma
Grace Baek, Gaurav Varma, Samuel Yamshon, et al.
American Journal of Hematology
|
February 7, 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study
Samuel Yamshon, Jean L Koff, Melissa C Larson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Transplantation and Cellular Therapy
|
February 4, 2023
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation
Mohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, et al.
Transplantation and Cellular Therapy
|
June 17, 2026
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis
Neela Easton, Mia Andreoli, Herman van Besien, et al.
JAMA Oncology
|
June 18, 2026
Second Primary Malignant Neoplasms After T-Cell-Engaging Bispecific Antibody Therapy: A Systematic Review and Meta-Analysis
Jaromir Tomasik, Tobias Tix, Mohammad Alhomoud, et al.
Haematologica
|
July 10, 2025
Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis
Mohammad Alhomoud, Rahma Ibrahim, Michelle Demetres, et al.
American Journal of Hematology
|
August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis
Jordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
Cancer Cell
|
December 6, 2024
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
Yusuke Isshiki, Xi Chen, Matt Teater, et al.
Blood Advances
|
May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
American Journal of Hematology
|
September 3, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies
Suheil Albert Atallah-Yunes, Chijioke C Nze, Rebecca L King, et al.
Blood Advances
|
March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin Lymphoma
Grace Baek, Gaurav Varma, Samuel Yamshon, et al.
American Journal of Hematology
|
February 7, 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study
Samuel Yamshon, Jean L Koff, Melissa C Larson, et al.
Page
of 4